Acquisition of the medication Entecavir 0.5 mg tablet

This tender, identified by process number EXO-PROC-3-2014-DARES/MINSA, concerns the acquisition of the medication Entecavir, specifically in a 0.5 mg tablet formulation. The contracting entity is the National Center for the Supply of Strategic Health Resources (CENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUD), operating under the Ministry of Health (MINSA) in Peru. The procurement is being conducted through an exemption method (Exoneración) and is managed by the DARES department. The tender is relevant to the health sector, focusing on the supply of essential pharmaceutical products. The specific location for this procurement is Lima. The objective is to ensure the availability of Entecavir, a medication commonly used in the treatment of chronic hepatitis B infection, by securing a supply of 0.5 mg tablets. This acquisition is critical for public health initiatives managed by the MINSA, aiming to provide necessary treatments to patients. The exemption method suggests a specific circumstance or urgency that allows for a streamlined procurement process, bypassing standard competitive bidding procedures. Further details regarding quantities, specifications, and delivery timelines would be available in the full tender documentation.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 1.3 million.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.